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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
• To assess the effects of automated telephone communication systems (ATCS) compared with usual care, for improving primary
preventive healthcare and management of long-term conditions in terms of: 1) behavioural change; 2) clinical outcomes; 3) process
outcomes; 4) cognitive outcomes; and 5) adverse outcomes.
• To determine which type of ATCS is most effective for primary preventive healthcare and management of long-term conditions.
• To explore which interventional design components may contribute to positive consumer behavioural change.
B A C K G R O U N D
Description of the condition
Primary preventive healthcare
Primary preventive healthcare focuses on keeping people well, pro-
tecting healthy people from developing a disease, preventing them
from experiencing an injury, or educating them to adopt lifestyles
that enable them to lead healthier lives (Family Health Teams
2006). Primary prevention strategies can be of two types: health
promotion and disease prevention (Figure 1). There is evidence to
suggest that disease prevention strategies can protect children from
preventable infectious diseases (e.g. child immunisation against
polio, diphtheria, and mumps) (Salisbury 2006). Similarly, evi-
dence suggests that people engaging in health promotion strategies
(e.g. education and counselling that promote smoking cessation)
are less likely to develop long-term conditions (Pearson 2002).
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Figure 1. Primary preventive healthcare
A major challenge for healthcare systems is to deliver preven-
tive activities that systematically target a number of cognitive, be-
havioural, physiological and affective factors that may be con-
tributing to ill health (Gullotta 2003). In the prevention of type
II diabetes, for example, a combination of cognitive, physiological
and behavioural factors (such as lack of knowledge around risk fac-
tors, lack of physical activity, and unhealthy diet) may contribute
to the development of the condition. An effective preventive strat-
egy would therefore need to take a holistic approach and target
each of the influencing factors (Figure 2).
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Figure 2. Influencing factors and preventive strategies in type 2 Diabetes
Central to devising an effective primary preventive strategy is to
have a complete and accurate account of the influencing factors
and their effects on individual and public health. Equally impor-
tant is that preventive activities are optimally delivered by appro-
priate interventions to reach the greatest number of individuals.
One possible method of communicating preventive activities to
the population is via information communication technology.
Management of long-term conditions
Long-term conditions such as cardiovascular disease, cancer, di-
abetes, and chronic lung disease, are the leading causes of death
globally (Alwan 2010). People with long-term conditions face
challenges such as dealing with complex symptoms, medication
regimens, disability, and lifestyle adjustments (Demiris 2004;
Wagner 1998; Wagner 2001). Disease Management Programmes
consist of a group of coherent interventions designed to man-
age one or more long-term conditions (and prevent a worsen-
ing state of condition) using a systematic, multidisciplinary ap-
proach employingmultiple treatmentmodalities (Schrijvers 2009;
Weingarten 2002). Disease Management Programmes may in-
clude self-monitoring and self-management interventions, pa-
tient and provider education, individualised care plans, and
telemedicine (RAND 2010; Webb 2006). They can lead to:
• improved control of long-term conditions;
• improved clinical processes of care (e.g. adherence to
evidence-based guidelines) (Weingarten 2002);
• improved quality of life;
• reduced hospital admission rates (Brandt 2010; Mattke
2007); and
• prevention of premature death (Alwan 2010).
Effective Disease Management Programmes can bring together
relevant information systems with continuous follow-up and tar-
geted management and can incorporate information communica-
tion technology to provide accessible and convenient educational
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information as well as self-management tools for people with long-
term conditions.
Emerging uses of information communication
technology in primary preventive healthcare and
management of long-term conditions
Today consumers increasingly use information communication
technology to:
1. access their own medical records through web portals;
2. communicate online with others, whether on a personal
basis or in a virtual community;
3. surf the Internet to find information about health and
health services; and
4. transmit health data or communicate messages using the
web or the telephone (Pappas 2011).
The use of information communication technology applications
to facilitate communication in health care has emerged through
consumer demand and government initiative (Dansky 2006;
Gupta 2008). Thismay facilitate active participation of consumers
in managing their own health (Maheu 2001). There is some evi-
dence that tools such as automated telephone communication sys-
tems (ATCS) can be successfully used to: deliver health informa-
tion to consumers which facilitates health promotion (Estabrooks
2009; Oake 2009); enable the active participation of consumers
in managing their own care; and facilitate epidemiological and
public health research by utilising collected patient data (Maheu
2001).
Information communication technology can also lend itself to the
delivery and administration of Disease Management Programmes.
There is evidence that ATCS can be successfully used to deliver
health information to patients which facilitates management of
long-term conditions (Derose 2009; Oake 2009).
Description of the intervention
ATCS incorporate a specialised computer technology to deliver
voice messages and collect information from consumers using ei-
ther their telephone’s touch-tone keypad or voice-recognition soft-
ware (Piette 2001). ATCS can be of three types:
1. Uni-directional ATCS enable non-interactive voice
communication and use one-way transmission of information or
reminders (Parikh 2010).
2. Interactive ATCS (e.g. Interactive Voice Response Systems)
enable real-time communication to provide feedback and
individualised interventions (Lee 2003; Reidel 2008). In
addition, they can be used as a data collection tool (Levin 2006).
Interactive ATCS have been used for the management of diabetes
(Graziano 2009; Piette 2000; Schillinger 2009), heart failure
(Weintraub 2010), coronary heart disease (Reid 2007), and
asthma (Bender 2010). They have also been used in health
promotion initiatives, including dietary behaviour (Delichatsios
2001), physical activity (Pinto 2002), and substance use (Alemi
1996).
3. ‘ATCS Plus’ interventions include ATCS with additional
functions, as described below (Webb 2010):
◦ Advanced communicative functions include: access to
an advisor to request advice (e.g. ’ask the expert’ facility),
scheduled contact with an advisor (e.g. telephone or face-to-face
meetings), and peer-to-peer access (e.g. buddy systems).
◦ Supplementary functions include: automated, non-
voice communication e.g. email and short messaging service
(SMS).
How the intervention might work
ATCS act as a mode of communication by which evidence-
based decision support can be delivered to consumers to enhance
their self-management skills, and thus empower them to effec-
tively manage their conditions (Bodenheimer 2002; Corbin 1988;
McCorkle 2011).
There is a growing recognition that ATCS interventions should be
informed by theoretically-driven models (Krupinski 2006; Revere
2001), such as the social cognition models. These include the: 1)
Trans-theoretical Model (Prochaska 1984); 2) Theory of Planned
Behaviour (Ajzen 1985); 3) Health Belief Model (Rosenstock
1974); 4) Self-efficacy Theory (Bandura 2001); and 5) Self-reg-
ulation Theory (Leventhal 1984). Self-management skills can be
developed using any of the social cognition models (Barlow 2002).
There is evidence to suggest that behaviour change interven-
tions underpinned by a theory can significantly enhance health
behaviours (Fisher 2007; Michie 2009; Webb 2010). Figure 3
provides a conceptual framework on how theories can influence
healthy behaviour.
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Figure 3. Conceptual framework of ATCS in preventive healthcare
Social cognition models assume that any health outcome is the
consequence of the complex interaction between social, economic,
psychological andbiomedical factors (Edelman 2000;Kelly2009).
These models focus on key concepts, such as self-efficacy and atti-
tudes to influence behaviour, which in turn can lead to behaviour
change (Hardeman 2005; Michie 2010).
Healthcare interventions delivered using Disease Management
Programmes, such as the Chronic CareModel, have produced im-
proved consumer care and health outcomes (Lee 2011; Piatt 2006;
Schillinger 2009). According to this model, management of long-
term conditions requires an interaction between a prepared, proac-
tive practice team and an informed, engaged consumer (Wagner
2002). This can be implemented through the interaction of ele-
ments such as self-management support, delivery system design,
decision support, and clinical information systems for optimal de-
livery of healthcare (Wagner 1998;Webb 2006). Figure 4 describes
a framework illustrating how ATCS in the management of long-
term conditions, using the Chronic Care Model, might work.
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Figure 4. Conceptual framework of ATCS in the management of LTCs
Advantages of automated telephone communication
systems
ATCS as a data collection tool have a number of advantages over
traditional face-to-face consultation. These include convenience,
simplicity, anonymity and low cost (Friedman 1998; Lee 2003).
ATCS provide access to health care 24 hours a day, 7 days a week
(Schroder 2009), and immediate feedback to the consumer (Hall
2000). Patients and healthcare professionals using ATCS have re-
ported a high degree of user satisfaction, noting that it is both
user-friendly and convenient (Abu-Hasaballah 2007; Hall 2000).
ATCS technology has been shown to facilitate access to diffi-
cult-to-reach populations (i.e. people from a lower socioeconomic
background) as ATCS require access only to a telephone (private or
public) (Piette 1999; Schroder 2009). ATCS have also been shown
to be acceptable to low-literacy populations (Glasgow 2004; Piette
2007) and frail elderly patients (Mundt 2001). Unlike face-to-face
interaction which can elicit socially desirable responses leading
to under-reporting of stigmatising behaviours and over-reporting
of socially desirable behaviours, ATCS have been found to elicit
greater self-reporting of sensitive issues (e.g. substance use, alcohol
use and sexual history) by reducing self-reporting bias (Alemagno
1996; Perrine 1995; Schroder 2009). They also have the poten-
tial to reduce healthcare delivery costs (Friedman 1997; Friedman
1998; Piette 2001).
Disadvantages of automated telephone
communication systems
Programming of ATCS involves investment in software and hard-
ware, for example to enable multiple simultaneous call-ins and
call-outs and the development of a script appropriate for the target
population and the topic of investigation (Piette 2007; Schroder
2009). ATCS may also present difficulties with the provision of
immediate participant support; should questions arise during the
interview (Schroder 2009), ATCS cannot capture, interpret, and
respond to the users’ non-verbal responses (Williams 2001). In-
dividuals with physical disabilities (e.g. severe loss of hearing or
speech) may have difficulty accessing ATCS (Mundt 2001). Oth-
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ers may simply have a strong preference for interactions with hu-
mans rather than with ATCS (Mahoney 2003). In addition, for
individuals targeted by several ATCS-based interventions, ATCS
could lead to informationoverload and outright rejection of the in-
terventions. Finally, protection of individually identifiable health
information could be a challenge.
Why it is important to do this review
Existing reviews found evidence of effectiveness of ATCS in
preventive healthcare or management of long-term conditions
(Krishna 2002; Oake 2009). However, neither explored the the-
oretical basis nor the mechanism of action of the intervention.
We will fill this gap by investigating the effects of interventions
based on theoretical constructs, as well as explore the behaviour
change techniques implemented in the intervention (Abraham
2008; Krupinski 2006; Michie 2005; Michie 2011). Where these
have been used to inform intervention design in trials, we will
seek to understand mechanisms of action by exploring potential
mediators of behaviour such as knowledge, intention, self-efficacy,
and emotions (Michie 2010).
In addition, it has not been identified which types of ATCS are
most effective for primary preventive healthcare ormanagement of
long-term conditions in what setting, and for which condition. If
the data permit, we will explore different interfaces of ATCS pro-
gramme design and layout that may be used for diverse population
groups (considering factors such as age, socioeconomic status, pre-
ferred language, and literacy) (Car 2004). Furthermore, healthcare
providers such as ‘Kaiser Permanente’, and long-term conditions
management companies such as ‘Healthways’ are contributing to
the evidence base in the management of long-term conditions by
evaluating ATCS’ effectiveness in trials (Estabrooks 2009; Mosen
2010; Simon 2010; Hamar 2010; Rosenzweig 2010).
A new systematic review is thus needed to guide the implementa-
tion of ATCS in preventive healthcare and management of long-
term conditions.
O B J E C T I V E S
• To assess the effects of automated telephone
communication systems (ATCS) compared with usual care, for
improving primary preventive healthcare and management of
long-term conditions in terms of: 1) behavioural change; 2)
clinical outcomes; 3) process outcomes; 4) cognitive outcomes;
and 5) adverse outcomes.
• To determine which type of ATCS is most effective for
primary preventive healthcare and management of long-term
conditions.
• To explore which interventional design components may
contribute to positive consumer behavioural change.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised controlled trials (RCTs) and quasi-
randomised trials (defined as: a trial where randomisation is at-
tempted but subject to potential manipulation, for example using
day of week, date of birth or sequence of entry into trial), inter-
rupted time series (ITS) and controlled before and after (CBA)
studies.Wewill include trials with individual and cluster randomi-
sation.
We will include CBA and ITS studies as they are often used to
draw conclusions about ’promising interventions’ ready for tri-
alling, when RCTs may be too expensive or simply impractical, or
where there are insufficient RCTs on a particular type of preven-
tive healthcare or long-term condition (Centre for Reviews and
Dissemination 2008; Higgins 2011; Jackson 2005). ITS designs
can address cyclical trends (i.e. the outcome may be increasing or
decreasing over time such as seasonal or other cyclical observa-
tions). To be included, these studies must meet the criteria speci-
fied by the Cochrane Effective Practice and Organisation of Care
ReviewGroup (EPOC) (Ryan 2009). ForCBAdesigns, the timing
of data collection for the control and intervention groups should
be the same, and there must be at least two intervention sites and
two control sites and both groups should be comparable on key
characteristics, i.e. with respect to demographics and intervention
context. For ITS designs, the studies should have a clearly defined
point in time when the intervention occurred and at least three
data points before and three after the intervention.
Types of participants
• We will include consumers, including carers, who receive
ATCS for primary preventive healthcare or management of long-
term conditions, regardless of age, gender, education, marital
status, employment status, or income.
• For management of long-term conditions, we will include
consumers who have one or more long-term conditions
concurrently (i.e. multi-morbidity).
• We will include consumers in all settings.
Types of interventions
We will include studies that evaluate either Uni-directional ATCS
or Interactive ATCS.Wewill also include studies that compare dif-
ferent ATCS (e.g. Uni-directional ATCS versus Interactive ATCS
and/or versus ‘ATCS Plus’) in order to compare the effects of dif-
ferent interventional designs on primary preventive healthcare or
management of long-term conditions.
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Interactive ATCS should have an automated function such as au-
tomated tailored feedback based on individual progress monitor-
ing (e.g. comparison to norms or goals, reinforcing messages, cop-
ing messages, and automated follow-up messages). ‘ATCS Plus’
interventions will be included if the study explicitly reports that
the effects of the intervention can be attributed to the ATCS com-
ponent.
In addition, the intervention should fall within one or more types
of primary preventive healthcare, or one or more types of long-
term conditions management, as illustrated in Figure 1 and Figure
5, respectively.
Figure 5. Management of LTCs
We will exclude studies in which interventions:
• target health professionals or teachers for educational
purposes;
• are exclusively for the purpose of electronic history-taking
or risk assessment with no health promotion or interactive
elements;
• involve only a non-ATCS component such as face to face
communication or written communication;
• are web-based interventions that are accessed via a mobile
phone; or
• evaluate the groups that receive similar ATCS components
but the interventions differ only by the advanced communicative
functions (such as access to an advisor) or supplementary
functions (such as email and short messaging service).
Control
Comparisons will be made against usual care (i.e. no ATCS inter-
vention). We will also include comparisons of one type of ATCS
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against another, or the same type of ATCS being delivered via
different delivery modes (e.g. landline telephone versus mobile
phone).
Types of outcome measures
Primary outcomes
Primary outcomes consist of health behaviour, and clinical out-
comes (formanagement of long-term conditions) (defined below).
For each study we will select only one primary outcome related to
health behaviour e.g. studies of ATCS for nutrition will have ‘di-
etary intake’ as the selected outcome. Multicomponent interven-
tions, such as ATCS for nutrition and physical activity, may have
multiple primary outcome measures (e.g. both dietary intake and
physical activity measures). However to select only one outcome
when multiple outcomes could be used, we will use the follow-
ing approach (used in previous EPOC reviews (Brennan 2009;
Grimshaw 2003; Hróbjartsson 2010; Jamtvedt 2006)):
• Select the primary outcome which has been identified by
the publication authors (we will take into consideration the
possibility of selective outcome reporting bias; we will attempt to
compare the primary outcomes stated in the protocol with the
ones listed in the review, to assist our judgement of this).
• When no primary outcome has been identified, select the
one specified in the sample size calculation.
• If there is no sample size calculation, rank the effect
estimates and select the median effect estimate.
Wewill report the following outcomes in the Summary of Findings
table:
1. Health behaviour outcomes (category): changes in health-en-
hancing behaviour (e.g. physical activity), or risk-taking behaviour
(e.g. tobacco consumption).
This outcome can be self-reported or collected using a validated
questionnaire that can be either self-administered or interview-
administered. In studies that measure the same outcome using
both a self-reportedmeasure and an objective measure, we will use
the objective measure. For example, if a study on physical activity
measures metabolic equivalent unit (MET) scores using a self-
reported 7-day physical activity recall as well as using a pedometer,
we will use the score obtained from the pedometer. Decisions on
objective measures used will be documented in the Characteristics
of Included Studies table.
2. Clinical outcomes (category): changes in physiological mea-
sures (e.g. blood pressure), blood biochemistry (e.g. glucose lev-
els).
Secondary outcomes
1. Process outcomes (category): change in acceptability of service
(e.g. consumer accessibility and usability of the interventions to
apply information and support supplied through ATCS), satisfac-
tion (e.g. patient and carer satisfaction with the intervention or
compliance (e.g. patient compliance with the treatment or medi-
cation and factors affecting compliance).
2 Cognitive outcomes (category): changes in knowledge (i.e.
knowledge of risk/accurate risk perception), attitude and inten-
tion to change, and/or self-efficacy (i.e. a person’s belief in their
capacity to carry out a specific action).
3. Adverse outcomes: Data on unintended adverse events at-
tributable to the intervention.
Search methods for identification of studies
Electronic searches
We will search the following electronic databases:
• The Cochrane Consumers and Communication Review
Group Specialised Register;
• The Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library, latest issue);
• MEDLINE (OvidSP) (1980 to present);
• EMBASE (OvidSP) (1980 to present);
• PsycINFO (OvidSP) (1980 to present);
• CINAHL (EbscoHOST) (1980 to present);
• Global Health (OvidSP) (1980 to present);
• WHOLIS (1980 to present);
• LILACS (1982 to present);
• Web of Science (1980 to present); and
• ASSIS (ProQuest) (1987 to present).
The strategy for MEDLINE (OvidSP) is presented in Appendix
1.
We will search databases from 1980 onwards for the following rea-
sons: 1) we expect that any evidence prior to 1980 will be incor-
porated into subsequent research; and 2) technology has advanced
dramatically over the last thirty years and integration of older re-
search should be interpreted only in light of the new findings.
Strategies will be tailored to other databases and reported in the
review.
There will be no language restrictions.
Searching other resources
Wewill search the grey literature (e.g.DissertationAbstracts, Index
to Theses, Australasian Digital Theses).
We will contact experts in the field and authors of included studies
for advice as to other relevant studies. We will also search ref-
erence lists of relevant studies, including all included studies and
previously published reviews.
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We will also search online trial registers (e.g. Current Controlled
Trials, www.controlled-trials.com; www.clinicaltrials.gov) for on-
going and recently completed studies.
Data collection and analysis
Selection of studies
We will merge search results across databases using the reference
management software EndNote, and remove duplicate records of
the same report. Two authors (LF and LCG) will then indepen-
dently examine titles and abstracts of records retrieved from the
search. We will retrieve the full text of the potentially-relevant
studies and assess their eligibility using the inclusion criteria. Mul-
tiple reports of the same study will be linked together, in order to
determine if the study is eligible for inclusion. Authors will corre-
spond with each other to make final decisions on study inclusion
and will resolve disagreement about study eligibility by discussion
with a third review author (YP).
If disagreement is not resolved, then we will place the article with
those ’awaiting assessment’ and will contact the study author for
clarification. We will also include any on-going trials if a study
author(s) provides interim outcome data, or the final data, ahead
of publication of their report. We will describe all the potentially-
relevant excluded studies in the ‘Characteristics for Excluded Stud-
ies’ table along with reasons for exclusion. We will use an adapted
PRISMA (Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) flow-chart to describe the study selection process
(Higgins 2011).
Data extraction and management
Two authors (LF and LCG) will independently extract relevant
population and intervention characteristics from all the included
studies using a standard data collection form; any disagreements
will be resolved by discussion. Any relevant missing information
on the trial will be sought from the original author(s) of the article,
if required. LF will transfer the data from the extraction form into
theReviewManager softwarewhile LCGwill confirm the accuracy
of the transferred data.
The Cochrane EquityMethods Group checklist (Equity Checklist
2009) will be used as part of the methods to conduct the review.
This will substantially enhance our reporting and analysis of pop-
ulation groups who may be missed.
Assessment of risk of bias in included studies
All studies meeting the inclusion criteria will be included regard-
less of the outcome of the assessment of risk of bias. We will assess
and report on the methodological risk of bias of included studies
in accordance with the Cochrane Handbook (Higgins 2011) and
the guidelines of the Cochrane Consumers and Communication
Review Group (Ryan 2011), which recommends the explicit re-
porting of the following individual elements for RCTs: random
sequence generation; allocation sequence concealment; blinding
(participants, personnel); blinding (outcome assessment); com-
pleteness of outcome data, selective outcome reporting; other
sources of bias. If quasi-randomised controlled trials, controlled
before and after studies and/or interrupted time series studies are
included in the review, we will assess their risk of bias systemati-
cally utilising adaptations to the above tool.
With studies that have used CBA or ITS designs, we will use
the risk of bias criteria suggested by the Cochrane Consumer and
Communication Review Group (Ryan 2011).
We will refer to the guidance provided by theCochrane Consumer
and Communication Review Group (Ryan 2011) to narratively
describe the results of risk of bias of each domain, for each in-
cluded study. We will report our assessment of risk of bias for each
domain, for each included study, with a descriptive summary of
our judgment.
In all cases, two authors (LF and LCG) will independently assess
the risk of bias of included studies, with any disagreements re-
solved by discussion and consensus. We will contact study authors
for additional information about the included studies, or for clari-
fication of the study methods as required. We will incorporate the
results of the risk of bias assessment into the review through stan-
dard tables, and systematic narrative description and commentary
about each of the elements, leading to an overall assessment of the
risk of bias of included studies and a judgment about the internal
validity of the review’s results.
Measures of treatment effect
For dichotomous data, we will report risk ratios. For studies that
report odds ratios, we will convert these results to risk ratios.
For continuous data from studies that assess the same outcome
measure, we will estimate mean differences (for studies using the
same scale) and standardized mean differences (for differences in
scale) between groups For CBA studies we will report relative per-
centage change post intervention and standardized mean differ-
ences.
We will report all data with their 95% confidence interval (Table
1). Where follow-up data were collected at different time periods,
wewill report results taken from the furthest points in time relative
to the intervention.
For ITS studies we will report the following estimates, and their P
values, from regression analyses which adjust for autocorrelation:
(i) change in level of the outcome at the first point after the intro-
duction of the intervention (immediate effect of the intervention),
(ii) the post-intervention slope minus the pre-intervention slope
(long-term effect of the intervention) (Brennan 2009).
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Unit of analysis issues
Where a study has more than one active treatment arm, data from
the appropriate arms for each of our main comparisons will be
extracted. If more than one treatment arm is relevant for a single
comparison, data from all appropriate armswill be included in that
comparison, and the comparator arm will be split equally between
each treatment arm, so that double counting of data does not
occur. In studies where the effects of clustering have not been taken
into account, we will adjust the standard deviations by the ’design
effect’, using intra-class coefficients if given in papers, or using
external estimates obtained from similar studies (Ukoumunne
1999) as advised by Higgins 2011.
Dealing with missing data
We will conduct an intention-to-treat analysis, including all those
who were randomised to either the ATCS group or control, re-
gardless of losses to follow-up and withdrawals (Higgins 2011).
Wherever possible, we will attempt to obtain missing data (e.g.
number of participants in each group, outcomes and summary
statistics) from the original author(s). For dichotomous outcomes,
data imputed case analysis can be used to fill in missing values.
This strategy imputes missing data according to reasons for ‘miss-
ingness’ and which essentially averages over several of the specific
imputation strategies (Higgins 2008). If the standard deviations
of continuous outcome data are missing, then we will try to cal-
culate the standard deviations from other statistics, such as 95%
confidence intervals, standard errors, or P values. If these are un-
available, then we will contact the author or impute the standard
deviations from other similar studies (Higgins 2008).
Assessment of heterogeneity
We will assess the heterogeneity meta-analysed data by a visual
inspection of the forest plot (providing a minimum of ten studies
are included) and by using the Chi2 test (with a significance level
of 0.10 in consideration of the low power of such tests). We will
quantify heterogeneity using the I2 statistic; we will examine the
I2 statistic that will describe the percentage of the variability in
effect estimates that is due to heterogeneity rather than sampling
error, where values of 50% or more indicate a substantial level
of heterogeneity (Higgins 2011). We will also take into account
clinically-relevant heterogeneity issues.
Assessment of reporting biases
Wewill evaluate funnel plots for asymmetry (providing there are at
least ten included studies in themeta-analysis). We will compute a
95% confidence interval on the expected variability of the research
(to be displayed on the sides of the funnel plot).
Funnel plots will be used as a means of investigating small study
effects that may have occurred due to the potential existence of
reporting biases (e.g. small study bias), to examine whether the
association between estimated intervention effects and a measure
of study size is greater than might be expected to occur by chance,
and to add further consideration to the visual inspection of the
funnel plot (Higgins 2011; Sterne 2011). We will also consider
other reasons for possible funnel plot asymmetry such as true het-
erogeneity or the risk of bias in included studies.
Data synthesis
Our decisions to meta-analyse or not will be based on an assess-
ment of whether participants (settings), intervention, comparison
and outcomes are sufficiently similar to ensure a clinically mean-
ingful result. We expect our included studies to be clinically het-
erogeneous (i.e. dissimilar in terms of the above mentioned terms)
giving rise to statistical heterogeneity. Therefore if a meta-analysis
is appropriate, we will use a random-effects model. We will display
the results of the meta-analysis in a forest plot that provides effect
estimates and 95% confidence intervals for each individual study
as well as a pooled effect estimate and 95% confidence interval.
If suitable numerical data are not available and/or if meta-analysis
is not appropriate (as in cases where there is an unclear or high risk
of bias for both allocation concealment and sequence generation,
or where the included studies are simply too heterogeneous to
be combined), we will then perform a narrative synthesis of the
evidence and present the summarised results in a table. We will
refer to the narrative synthesis framework to guide this process
(Rodgers 2009). We will use the following steps to describe the
studies:
• develop a preliminary synthesis by grouping the included
studies by the type of primary prevention or long-term condition
(in the case of management of long-term conditions) and
intervention;
• describe the inclusion criteria (especially participants,
interventions, comparators, and outcome elements) along with
the reported findings for each of the included studies;
• include an additional table to describe the intervention
components including the type of ATCS; behaviour change
theories; behaviour change techniques (Michie 2011); content
delivery; frequency, intensity and duration of the intervention;
interaction mode; and data entry method;
• explore the relationships between characteristics of
individual studies and their reported findings as well as those
between the findings of different studies;
• describe the moderators as well as the mediators that would
have an impact on the intervention effects; and
• use the summary of the risk of bias of an outcome across
studies to judge the robustness of the evidence.
We will not meta-analyse the CBA and ITS study results; instead,
we will use the narrative synthesis framework, described above, to
report such results.
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We will perform the statistical analysis using RevMan version 5.2.
We will adhere to the statistical guidelines described in Higgins
2011.
We will use the GRADE system to assess the quality of the evi-
dence, the magnitude of effect of the interventions examined, and
the sum of available data on the main outcomes, and to produce
a Summary of Findings table (Higgins 2011). We will present
one table for each different interventional comparison (e.g. ATCS
versus no ATCS), and present broad outcome results by outcome
categories (e.g. for the health behavior outcome category, we will
present the results under the two broad subheadings: health-en-
hancing behaviour and risk-taking behaviour).
Subgroup analysis and investigation of heterogeneity
Wewill conduct subgroup analyses depending on the types of long-
term condition being managed (Figure 5) and primary preventive
healthcare (Figure 1). If there is substantial heterogeneity in the
pooled effect between the intervention and the control group, we
will assess the causes of heterogeneity and explore subgroup effects
using a random effects meta-analysis. These include:
• type of ATCS (Unidirectional, Interactive or ATCS Plus);
• type of primary preventive health care (Figure 1);
• type of long-term conditions (Figure 5);
• language (for studies in languages other than English);
• country’s income level (for studies undertaken in ‘high
income countries’, ‘middle income countries’, or ‘low income
countries’ as defined by the World Bank’s Income Level data
(World Bank 2012));
• source of funding (Industry versus other); and
• theoretical models (where applicable, included studies will
be separated depending on the type of theoretical model that has
been used to inform the design of the intervention).
If at least 10 studies are available for each outcome, we will per-
formmeta-regression. This will be implemented in Stata using the
‘metareg’ command and including trial characteristics as covari-
ates.
As we intend to include many variables, to reduce misleading con-
clusions resulting from multiple statistical analyses we will inter-
pret statistically significant findings in the context of how many
analyses were undertaken and adjust the level of significance to
account for making multiple comparisons, with the assistance of
a statistician (LG).
Sensitivity analysis
Wewill consider performing sensitivity analyses (using the criteria
discussed in the ‘Assessment of risk of bias in included studies’
section, and as recommended by Higgins 2011) including:
• studies with low risk of bias in the selection bias domain,
i.e. sequence generation and allocation concealment
• studies with low risk of bias in the attrition bias domain, i.e.
incomplete outcome data
• fixed-effect model for all the studies
• fixed-effect model for studies with low risk of bias in the
selection bias domain
• fixed-effect model for studies with low risk of bias in the
attrition bias domain
Consumer participation
Involvement of non-governmental organisations that represent a
range of potential user groups will be an important part of the
project development. We will contact non-governmental organi-
sations such as the Diabetes Research Network and request one
of their members to represent in our steering committee meetings
to guide us in the review process, particularly in considering out-
comes of interest to users, and methods of disseminating results
to user communities. This protocol has been peer reviewed by
at least one consumer, as part of the Cochrane Consumers and
Communication Review Group’s standard editorial process; the
review will likewise be peer reviewed by at least one consumer. We
will also seek additional feedback from members of the Cochrane
Consumer Network at draft review stage.
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